Adamas Pharmaceuticals Inc Revenue per Employee (ADMS), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Adamas Pharmaceuticals Inc  (NASDAQ: ADMS)
 

Adamas Pharmaceuticals Inc's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 28.35% in the third quarter 2021, year on year to cumulative value of $88 million, Adamas Pharmaceuticals Inc's revenue per employee grew on a trailing twelve months basis to $ 734,908, this marks a new company high.
Within the Healthcare sector Employees of 19 other companies have achieved higher revenue per employee. While Adamas Pharmaceuticals Inc's total ranking has deteriorated compared to the previous quarter from 0 to 579. Adamas Pharmaceuticals Inc has 120 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ADMS Revenue per Employee (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter		 (Sep 30 2020)
III. Quarter
Y / Y Revenue Change 28.35 % 16.91 % 33.35 % 28.52 % 44.81 %
Sales per Employee (TTM) $ 734,908 687,242 660,758 620,508 581,658
ADMS's Total Ranking # 579 # 0 # 0 # 0 # 0
Seq. Revenue Change 17.86 % 13.78 % -8.09 % 4.13 % 7.35 %

ADMS Company Profile >> Back to ADMS Efficiency Comparisons >> Compare ADMS Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 9
Healthcare Sector # 20
Overall Market # 579

Revenue per Employee Statistics
High Average Low
$ 734,908 $ 357,868 $ 4,767
(Sep 30 2021)   (Dec 31 2016)



Financial Statements
Adamas Pharmaceuticals Inc's Revenue MRQ $ 26 Millions Visit ADMS's Income Statement
Adamas Pharmaceuticals Inc's Revenues TTM $ 88 Millions Visit ADMS's aggregate revenue growth
What are ADMS's Sales? Visit ADMS's Sales by Segment




Other Ratios
Adamas Pharmaceuticals Inc's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
ADMS's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for ADMS's Competitors
Revenue per Employee for ADMS's Suppliers
Revenue per Employee for ADMS's Customers

You may also want to know
ADMS's Sales Growth Rates ADMS's Pe Price to earnings ratio ADMS's Receivables Turnover Ratio ADMS's Stock Quote
ADMS's Net Income Growth Rates ADMS's Ps Price to Sales ratio ADMS's Sales per Employee ADMS's Asset Turnover Ratio
ADMS's Net Margin ADMS's Pb Price to Book ratio ADMS's Financial Strength Ratios ADMS's Dividend Payout Ratio
Date modified: 2026-08-29T17:26:45+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2021, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2021Number of Employees Sep 30 2021
Acorda Therapeutics Inc   1,277,088.24 $ 130.263  Million 102 
Integrated Biopharma Inc  1,222,760.00 $ 61.138  Million 50 
United Therapeutics Corporation  1,182,285.71 $ 1,655.200  Million 1,400 
Anaptysbio Inc   1,174,653.85 $ 122.164  Million 104 
Siga Technologies Inc  1,143,725.71 $ 56.043  Million 49 
Bionexus Gene Lab Corp   1,130,406.53 $ 21.478  Million 19 
Halozyme Therapeutics Inc   1,094,586.29 $ 463.010  Million 423 
Exelixis Inc   1,093,183.96 $ 1,253.882  Million 1,147 
Akebia Therapeutics Inc   1,085,938.14 $ 210.672  Million 194 
Scienture Holdings Inc   1,055,092.11 $ 9.496  Million 9 
Incyte Corporation  1,024,234.53 $ 2,912.923  Million 2,844 
Endo International Plc  1,011,258.27 $ 2,963.998  Million 2,931 
Collegium Pharmaceutical Inc   1,000,787.23 $ 423.333  Million 423 
Ontrak Inc   990,884.62 $ 103.052  Million 104 
Jazz Pharmaceuticals Plc  990,665.74 $ 2,863.024  Million 2,890 
Alpine Immune Sciences Inc   986,800.00 $ 24.670  Million 25 
Lifevantage Corp  980,170.40 $ 218.578  Million 223 
Abiomed Inc   973,635.00 $ 973.635  Million 1,000 
Abbvie Inc   967,877.19 $ 55,169.000  Million 57,000 
Cytomx Therapeutics Inc   959,695.65 $ 66.219  Million 69 
Dynavax Technologies Corporation  956,080.00 $ 262.922  Million 275 
Journey Medical Corp  949,379.31 $ 55.064  Million 58 
Intercept Pharmaceuticals inc   944,885.33 $ 354.332  Million 375 
Harmony Biosciences Holdings inc   923,259.39 $ 270.515  Million 293 
Healthlynked Corp  913,454.80 $ 9.135  Million 10 
Co diagnostics Inc   909,821.43 $ 104.629  Million 115 
Cartesian Therapeutics Inc   894,546.67 $ 67.091  Million 75 
Harpoon Therapeutics Inc   894,033.33 $ 26.821  Million 30 
Regeneron Pharmaceuticals Inc   878,838.42 $ 13,542.900  Million 15,410 
Supernus Pharmaceuticals inc   865,463.19 $ 564.282  Million 652 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.